Latest Breaking News On - Okyo pharma ltd - Page 1 : comparemela.com

OKYO Pharma to include additional analyses in upcoming dry eye disease Key Opinion Leader event

OKYO Pharma to include additional analyses in upcoming dry eye disease Key Opinion Leader event
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Gary jacobOkyo pharma ltdAssociation for researchKey opinion leaderHorizons symposium navigatingDry eye research

OKYO Pharma to Reschedule Key Opinion Leader Event in Dry

LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing.

City ofUnited kingdomGarys jacobPaul spencerGary jacobBusiness development investor relationsAssociation for researchPharma limitedCompany phaseKey opinion leaderComprehensive detailed resultsDry eyeHorizons symposium navigatingFriday mayFour seasons seattleChief executive

OKYO Pharma shares surge on FDA clearance of Phase 2 neuropathic corneal pain trial

OKYO Pharma shares surge on FDA clearance of Phase 2 neuropathic corneal pain trial
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesGarys jacobPedram hamrahTufts medical center as principal investigatorOkyo pharma ltdDrug administrationInvestigational new drugAdvisory boardTufts medical center

OKYO Pharma appoints leading ophthalmologists to Scientific Advisory Board

OKYO Pharma appoints leading ophthalmologists to Scientific Advisory Board
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesPedram hamrahGarys jacobVictor perezMark milnerJay peposeUniversity of miami miller school medicineOkyo pharma ltdBascom palmer eye instituteMiami va medical centerCornea research at bascom palmer eye instituteScientific advisory boardCornea researchMiami miller schoolAnat galorGoldman eye

OKYO Pharma reports 'statistical significance' achieved in Phase 2 trial of OK-101 in dry eye disease

OKYO Pharma reports 'statistical significance' achieved in Phase 2 trial of OK-101 in dry eye disease
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Jay peposeRaj patilGabriele cerroneOkyo pharma ltdDrug administrationPepose vision instituteDry eyeDeveloping drugsClinical ophthalmologyWashington university school